NEW YORK, Nov. 9, 2015 /PRNewswire/ -- At over $2 billion in IVD market revenue, diagnostic tests for human immunodeficiency virus (HIV) infections are found across segments, including immunoassays, molecular assays, and blood screening assays, according to Kalorama Information. Although a comparatively mature market segment of infectious disease diagnostics, HIV diagnostics is finding growth through the expansion of disease control programs in the developing world and more sophisticated assays used in conjunction with treatment. The finding was made in Kalorama Information's report, The World Market for Infectious Disease Testing.
"Treatment of chronic HIV infection using antiretroviral (ART) drugs has added significant value to the HIV test market and has driven demand for more sophisticated and higher value assays," said Emil Salazar, IVD industry analyst and author of the report.
The viral pathogen has influenced the reformulation of clinical and public health approaches to infectious diseases that treat them as chronic disease burdens rather than individual health episodes. Infectious diseases represent a significantly greater share of the total disease burden in developing countries than in the developed world. For HIV specifically, the case is much the same. The WHO has estimated that 75% of the global HIV disease burden – measured in disability-adjusted life years (DALY; combining years lost to disability and premature mortality) – is found in low-income countries.
HIV diagnosis in the developing world is predominately accomplished using rapid immunoassays procured by global aid organizations such as the Clinton Foundation HIV/AIDS Initiative, Roll Back Malaria, UNAIDS, United States President's Emergency Plan for Aids Relief (PEPFAR), the Global Fund to Fight AIDS, and Tuberculosis and Malaria, and World Health Organization. Diverse vendors from throughout the world are used under these programs, but few are smaller.
"Dynamic areas of molecular HIV testing include viral tropism and viral resistance testing," Salazar said.
For more information, Kalorama's complete study of the market, The World Market for Infectious Disease Tests is available at their website at: http://www.kaloramainformation.com/redirect.asp?progid=88016&productid=9367616.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kalorama-information-hiv-among-diseases-driving-testing-sales-300174306.html
SOURCE Kalorama Information